Biologicals

Yellow Fever

Requirements for yellow fever vaccine, Annex 2

(Requirements for Biological Substances, No. 3, revised 1995) WHO Technical Report Series, No. 872, 1998

Proposed amendments to the Requirements for Yellow Fever Vaccines (Requirements for Biological Substances No. 3, Annex 2) WHO Technical Report Series No. 872

UPCOMING EVENTS

WHO Drafting Group Meeting on the Revision of TRS 962, Annex 1

(Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines) 29-30 April 2014, WHO/HQ, Geneva

Implementation Workshop on Evaluation of Biotherapeutic Products and Evaluation of Similar Biotherapeutic products with emphasis on Monoclonal Antibody Products

13-16 May 2014, Seoul, The Republic of Korea

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971